(2.)Positions

 

Month/Year(s)

Position Title

Department (Division, if applicable)

Institution

07/2007-12/2010

Resident

Department of General Surgery

Second Affiliated Hospital, Xi’an Jiaotong University, China

01/2011-08/2012

Attending Physician

Department of General Surgery

Second Affiliated Hospital, Xi’an Jiaotong University, China

07/2015-present

Attending Physician

Department of General Surgery

Second Affiliated Hospital, Xi’an Jiaotong University, China

Basic Information

Liu Yang, MD, PhD,

Associate professor

Supervisor of postgraduate

General & gastroenterology surgery department

  •  
Education

Education:

Month/Year(s)

Degree

Fields of Study  (Thesis advisor for doctoral research degrees)

Institution

09/1999-07/2004

Bachelor

clinical medicine

Xi’an Jiaotong University, China

09/2004-07/2007

Master

Surgery (Lv Yi)

First Affiliated Hospital, Xi’an Jiaotong University, China

09/2012-06/2015

MD

Surgery (Li Yiming)

Second Affiliated Hospital, Xi’an Jiaotong University, China

Postdoctoral Training:

 

Month/Year(s) 

Title 

Specialty/Discipline (Lab PI for postdoctoral research)

Institution

05/2017-now

Postdoc

Surgery

Harvard medicine school, Massachusetts general hospital

(6.)Teaching

请为该模块添加内容!
(4.)Honors

请为该模块添加内容!
(5.)Scientific Research

请为该模块添加内容!
(7.)Contact

 Email: yliu81@mgh.harvard.edu

            individualliu@163.com

Blank

    多年来一直从事普通外科专业工作,对肝、胆、胰、脾、胃肠、甲状腺及腔镜外科均有深入研究。2017年起在美国哈佛大学附属麻省总医院接受博士后训练,师从前美国大学外科学会主席Hodin教授。第一作者发表论文十余篇,授权国家发明专利4项,主持国家自然科学基金及陕西省自然科学基金各1项,第二参与人参与国家级项目三项,全面负责项目申请及实施。教学方面主编西安交通大学“十三-五”规划教材一部,并多次获评医院优秀教师,并主持陕西省高教研究项目一项。

Blank1

请为该模块添加内容!
Blank2

请为该模块添加内容!
Blank3

     The major focus of our group is to unravel the molecular mechanisms that underline the processes of cell growth and differentiation relate to intestinal barrier. Intestinal bacteria could translocate into liver by portal vein in the normal circumstance and this phenomenal will increase when intestinal barrier impair and/or intestinal bacteria over growth. Our various ongoing projects relate to understanding the differentiation process in the contexts of:

1. Normal development

2. Homeostasis within the adult

3. Pathological conditions such as starvation, cancer, aging, diabetes and alcohol consumption. 

Blank4

 

Innovation (date if applicable)

Patent, if any, pending or awarded /If described in print/on web, provide citation

 

Describe the influence or potential influence of the innovation on research or clinical care, including how the material is used locally (at HMS), regionally, nationally or internationally; if developed as a member of a team, describe your contribution (1-2 sentences)

A new auxiliary automatic equipment for encoscopic retrograde cholangio-pancreatography.

China Patent Application, 201010244305.9, filed November 24 2011/ http://cpquery.sipo.gov.cn

 

I, together with my colleague, designed an automatic equipment which can perfume ERCP by remote control. We only built an prototype of a machine for experiment test, but not put in to practice.  In this patent, I provide the idea.

A new auxiliary automatic equipment for percutaneous transhepatic cholangial drainage

China Patent Application, 2010102442836, filed December 29 2010/ http://cpquery.sipo.gov.cn

 

I, together with my colleague, designed an automatic equipment which can perfume PTCD by remote control. This equipment is still in development, but not put in to practice.  In this patent, I provide the idea.

A new auxiliary automatic equipment for vascular interventional technique.

China Patent Application, 201010244273.2, filed August  02 2010/ http://cpquery.sipo.gov.cn

 

I, together with my colleague, designed an automatic equipment which can perfume vascular interventional technique by remote control. This patent isn’t put into practice since less of funding support.  In this patent, I provide the idea.

A pulsatile blood pump for portal vein

China Patent Application, 201020211779.9, filed June 01 2010/ http://cpquery.sipo.gov.cn

 

This equipment which can increase the blood flow into the liver is use for the patient with portal hypertension. The equipment isn’t put in to clinical use since some deficient couldn’t be solved.

Blank5

请为该模块添加内容!
Blank6

 Past

Year(s) funded

Grant title

 

Grant agency type and number Grant title

 

Role on Project (if PI, multiple PI  or site PI, total direct costs)

 

Description of the major goalsDescription of the major goals

01/2009-12/2011

Platelet derived serotonin role in activation of hepatic satellite cell

 

National Natural Science Foundation of China   30872482

 

Co-Investigator (PI: Liu Chang)

 

The major goal of the study is to seek whether the platelet derived serotonin take part in the activation of the hepatic satellite cell.

Current

Year(s) funded

Grant title

 

Grant agency type and number Grant title

 

Role on Project (if PI, multiple PI  or site PI, total direct costs)

 

Description of the major goalsDescription of the major goals

01/2013-12/2016

A ERCP automation equipment development.

 

National Natural Science Foundation of China   81270562

 

Co-Investigator (PI: Cao Gang)

 

The major goal of the study is to design and develop an automation equipment which can perform the ERCP.

01/2014-12/2016

Platelet derived serotonin role in hepatocellular carcinoma

 

Scientific Foundation of Second Affiliated Hospital, Xi’an Jiaotong University. RC(XM)201308

 

PI (¥ 30,000 - total direct costs)

 

This project seek the role of the platelet counts and platelet derived serotonin in hepatocellular carcinoma growth.

01/2015-12/2016

Chronic alcohol consumption accelerates hepatocellular carcinoma genesis  by intrahepatic translocation of intestinal bacteria

 

Natural Science Foundation of Shannxi Province of China    2015JM8389

 

PI (¥ 50,000 - total direct costs)

 

The major goal of the project is to define the role of  intestinal bacteria in alcoholic hepatocellular carcinoma genesis.

01/2017-12/2019

Chronic alcohol consumption accelerates hepatocellular carcinoma genesis via activation TLR9 mediated by the formation of NETs following intrahepatic translocation of intestinal bacteria

 

National Natural Science Foundation of China    81602401

 

PI (¥ 170,000 - total direct costs)

 

This study seek the reason why the incidence of hepatocellular carcinoma is increase during chronic alcohol consumption.

Blank7

1.     Liu Y, Zhang ZY. Serotonin receptor agonist quipazine promotes proliferation and apoptosis of human hepatocyte strain of L-02 strain. Hepatobiliary Pancreat Dis Int[J], 2009, 8(3): 278-281.

2.     Liu Y, Wang J, Yang P, et al. Delayed rearterialization unlikely leads to nonanastomotic stricture but causes temporary injury on bile duct after liver transplantation. Transpl Int[J], 2015, 28(3): 341-351.

3.     Liu Y, Li YM, Yang WB, et al. [Endovenous laser ablation versus conventional surgery for great saphenous varicose veins:meta-analysis of randomized trials]. Zhonghua yi xue za zhi[J], 2013, 93(23): 1822-1826.

4.     Liu Y, Li Y, Yang W, et al. Anti-hepatoma activity in mice of a polysaccharide from the rhizome of Anemone raddeana. Int J Biol Macromol[J], 2012, 50(3): 632-636.

5.     Liu Y, Li Y, Yang W, et al. H2 S inhibits the activation of hepatic stellate cells and downregulates the expression of urotensin II. Hepatol Res[J], 2013, 43(6): 670-678.

6.     Liu Y, Li Y, Ma J, et al. A modified Hassab's operation for portal hypertension: experience with 562 cases. J Surg Res[J], 2013, 185(1): 463-468.

7.     Zhang J, Pang Q, Song S, et al. Role of Serotonin in MODS: Deficiency of Serotonin Protects Against Zymosan-Induced Multiple Organ Failure in Mice. Shock[J], 2015, 43(3): 276-284.

8.     Wang JZ, Liu Y, Wang JL, et al. Sequential vs simultaneous revascularization in patients undergoing liver transplantation: A meta-analysis. World J Gastroenterol[J], 2015, 21(22): 7036-7046.

9.     Wang JZ, Liu Y, Wang JL, et al. Hepatic artery bridging lessens temporary ischemic injury to bile canaliculi. World J Gastroenterol[J], 2015, 21(35): 10113-10125. 

10.  Lu L, Wang J, Lu H, et al. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARgamma expression: A rat fibrosis model study. Biochem Biophys Res Commun[J], 2015, 465(3): 387-393.

Blank8

请为该模块添加内容!
Blank9

        1.     Liu Y, Zhang ZY. Serotonin receptor agonist quipazine promotes proliferation and apoptosis of human hepatocyte strain of L-02 strain. Hepatobiliary Pancreat                    Dis Int[J], 2009, 8(3): 278-281.

2.     Liu Y, Wang J, Yang P, et al. Delayed rearterialization unlikely leads to nonanastomotic stricture but causes temporary injury on bile duct after liver transplantation. Transpl Int[J], 2015, 28(3): 341-351.

3.     Liu Y, Li YM, Yang WB, et al. [Endovenous laser ablation versus conventional surgery for great saphenous varicose veins:meta-analysis of randomized trials]. Zhonghua yi xue za zhi[J], 2013, 93(23): 1822-1826.

4.     Liu Y, Li Y, Yang W, et al. Anti-hepatoma activity in mice of a polysaccharide from the rhizome of Anemone raddeana. Int J Biol Macromol[J], 2012, 50(3): 632-636.

5.     Liu Y, Li Y, Yang W, et al. H2 S inhibits the activation of hepatic stellate cells and downregulates the expression of urotensin II. Hepatol Res[J], 2013, 43(6): 670-678.

6.     Liu Y, Li Y, Ma J, et al. A modified Hassab's operation for portal hypertension: experience with 562 cases. J Surg Res[J], 2013, 185(1): 463-468.

7.     Zhang J, Pang Q, Song S, et al. Role of Serotonin in MODS: Deficiency of Serotonin Protects Against Zymosan-Induced Multiple Organ Failure in Mice. Shock[J], 2015, 43(3): 276-284.

8.     Wang JZ, Liu Y, Wang JL, et al. Sequential vs simultaneous revascularization in patients undergoing liver transplantation: A meta-analysis. World J Gastroenterol[J], 2015, 21(22): 7036-7046.

9.     Wang JZ, Liu Y, Wang JL, et al. Hepatic artery bridging lessens temporary ischemic injury to bile canaliculi. World J Gastroenterol[J], 2015, 21(35): 10113-10125.

10.  Lu L, Wang J, Lu H, et al. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARgamma expression: A rat fibrosis model study. Biochem Biophys Res Commun[J], 2015, 465(3): 387-393.

版权所有:西安交通大学 站点设计:网络信息中心 陕ICP备05001571号 IPhone版本下载 IPhone版本下载    Android版本下载 Android版本下载
欢迎您访问我们的网站,您是第 位访客
推荐分辨率1024*768以上 推荐浏览器IE7 Fifefox 以上